help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on December 18, 2003
Molecular Endocrinology, doi:10.1210/me.2003-0145
Molecular Endocrinology Vol. 0, No. 2003 200301451-
doi:10.1210/me.2003-0145
Copyright © 2003 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Movies
Right arrow All Versions of this Article:
18/4/834    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Black, B. E.
Right arrow Articles by Paschal, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Black, B. E.
Right arrow Articles by Paschal, B. M.
Right arrowPubmed/NCBI databases
*Genetics Home Reference

Submitted on April 17, 2003
Accepted on November 26, 2003

Transient, Ligand-dependent Arrest of the Androgen Receptor in Sub-Nuclear Foci Alters Phosphorylation and Co-activator Interactions

Ben E. Black1, Michael J. Vitto1, Daniel Gioeli1, Adam Spencer1, Nima Afshar1, Mark R. Conaway1, Michael J. Weber1, and Bryce M. Paschal1*

1 Center for Cell Signaling, Department of Biochemistry and Molecular Genetics, Cell and Molecular Biology Program, and Department of Microbiology, Department of Health Evaluation Sciences; University of Virginia, Charlottesville, VA 22908

* To whom correspondence should be addressed. E-mail: paschal{at}virginia.edu.

Here we report that mutations within the DNA-binding domain of AR, shown previously to inhibit nuclear export to the cytoplasm, cause an androgen-dependent defect in intra-nuclear trafficking of AR. Mutation of two conserved phenylalanines within the DNA recognition helix (F582,583A) results in androgen-dependent arrest of AR in multiple sub-nuclear foci. A point mutation in one of the conserved phenylalanines ({Delta}F582,F582Y) is known to cause Androgen Insensitivity Syndrome (AIS). Both AIS mutants ({Delta}F582,F582Y) and the export mutant (F582,583A) displayed androgen-dependent arrest in foci, and all three mutants promoted androgen-dependent accumulation of the histone acetyl transferase CBP in the foci. The foci correspond to a sub-nuclear compartment that is highly enriched for the steroid receptor co-activator GRIP-1. Agonist-bound WT AR induces the redistribution of GRIP-1 from foci to the nucleoplasm. This likely reflects a direct interaction between these proteins because mutation of a conserved residue within the major co-activator binding site on AR (K720A) inhibits AR-dependent dissociation of GRIP-1 from foci. GRIP-1 also remains foci-associated in the presence of agonist-bound F582,583A, {Delta}F582, or F582Y forms of AR. Two-dimensional phospho-peptide mapping and analysis with a phospho-specific antibody revealed that mutant forms of AR that arrest in the sub-nuclear foci are hypo-phosphorylated at Ser81, a site that normally undergoes androgen-dependent phosphorylation. Our working model is that the sub-nuclear foci are sites where AR undergoes ligand-dependent engagement with GRIP-1 and CBP, a recruitment step that occurs before Ser81 phosphorylation and association with promoters of target genes.


Key words: Androgen receptor • GRIP-1 • CBP • nuclear transport

NURSA Molecule Pages Link:

Nuclear Receptors:   COUP-TFII  |  GR  |  AR
Coregulators:   CBP  |  GRIP1  |  SMRT
Ligands:   Dexamethasone  |  R1881



This article has been cited by other articles:


Home page
Hum Mol GenetHome page
G. N. Corry, M. J. Hendzel, and D. A. Underhill
Subnuclear localization and mobility are key indicators of PAX3 dysfunction in Waardenburg syndrome
Hum. Mol. Genet., June 15, 2008; 17(12): 1825 - 1837.
[Abstract] [Full Text] [PDF]


Home page
J. Histochem. Cytochem.Home page
H. Nakauchi, K.-i. Matsuda, I. Ochiai, A. Kawauchi, Y. Mizutani, T. Miki, and M. Kawata
A Differential Ligand-mediated Response of Green Fluorescent Protein-tagged Androgen Receptor in Living Prostate Cancer and Non-prostate Cancer Cell Lines
J. Histochem. Cytochem., June 1, 2007; 55(6): 535 - 544.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Lin, P. Philibert, B. Ferraz-de-Souza, D. Kelberman, T. Homfray, A. Albanese, V. Molini, N. J. Sebire, S. Einaudi, G. S. Conway, et al.
Heterozygous Missense Mutations in Steroidogenic Factor 1 (SF1/Ad4BP, NR5A1) Are Associated with 46,XY Disorders of Sex Development with Normal Adrenal Function
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 991 - 999.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Chen, Y. Xu, X. Yuan, G. J. Bubley, and S. P. Balk
Androgen receptor phosphorylation and stabilization in prostate cancer by cyclin-dependent kinase 1
PNAS, October 24, 2006; 103(43): 15969 - 15974.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
V. Georget, W. Bourguet, S. Lumbroso, S. Makni, C. Sultan, and J.-C. Nicolas
Glutamic Acid 709 Substitutions Highlight the Importance of the Interaction between Androgen Receptor Helices H3 and H12 for Androgen and Antiandrogen Actions
Mol. Endocrinol., April 1, 2006; 20(4): 724 - 734.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. Grenier, A. Trousson, A. Chauchereau, J. Cartaud, M. Schumacher, and C. Massaad
Differential Recruitment of p160 Coactivators by Glucocorticoid Receptor between Schwann Cells and Astrocytes
Mol. Endocrinol., February 1, 2006; 20(2): 254 - 267.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. S. Taneja, S. Ha, N. K. Swenson, H. Y. Huang, P. Lee, J. Melamed, E. Shapiro, M. J. Garabedian, and S. K. Logan
Cell-specific Regulation of Androgen Receptor Phosphorylation in Vivo
J. Biol. Chem., December 9, 2005; 280(49): 40916 - 40924.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
M-B Debril, L Dubuquoy, J-N Feige, W Wahli, B Desvergne, J Auwerx, and L Gelman
Scaffold attachment factor B1 directly interacts with nuclear receptors in living cells and represses transcriptional activity
J. Mol. Endocrinol., December 1, 2005; 35(3): 503 - 517.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C.-S. Yang, M. J. Vitto, S. A. Busby, B. A. Garcia, C. T. Kesler, D. Gioeli, J. Shabanowitz, D. F. Hunt, K. Rundell, D. L. Brautigan, et al.
Simian Virus 40 Small t Antigen Mediates Conformation-Dependent Transfer of Protein Phosphatase 2A onto the Androgen Receptor
Mol. Cell. Biol., February 15, 2005; 25(4): 1298 - 1308.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
J Kim, L Jia, M R Stallcup, and G A Coetzee
The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus
J. Mol. Endocrinol., February 1, 2005; 34(1): 107 - 118.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Hoang, I. S. Fenne, C. Cook, B. Borud, M. Bakke, E. A. Lien, and G. Mellgren
cAMP-dependent Protein Kinase Regulates Ubiquitin-Proteasome-mediated Degradation and Subcellular Localization of the Nuclear Receptor Coactivator GRIP1
J. Biol. Chem., November 19, 2004; 279(47): 49120 - 49130.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society